Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata often have lower vitamin D levels, which may be linked to the condition's severity.

Experts recommend personalized treatment plans for alopecia areata, using corticosteroids and minoxidil for mild cases, and stronger medications for severe cases.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Hair loss and mental health issues like anxiety and insomnia affect each other, impacting quality of life.

Minoxidil with triamcinolone acetonide is more effective for mild alopecia areata when injected with microneedles than when applied topically.

AlopeciaDet accurately detects Alopecia Areata early using advanced image analysis.

Alopecia Areata is linked to higher depression levels.

AiQingHua oil improves blood flow and promotes hair growth in mice.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Supplements improved calves' haircoat condition.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

Hair follicles significantly increase the speed and amount of caffeine absorbed through the skin.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Low-dose minoxidil effectively enhances facial hair with minimal side effects.

Intralesional triamcinolone is more effective than cryotherapy for treating alopecia areata in middle-aged adults.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

Diphenylcyclopropenon treatment for Alopecia areata is effective and safe, improving patients' quality of life.

More severe hair loss in alopecia areata greatly impacts patients and caregivers.

The STRIAA tool helps doctors quickly and effectively assess the severity of Alopecia Areata.

The EQ-5D-5L tool may not accurately measure the impact of alopecia areata on patients' lives.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Ixekizumab effectively treated severe psoriasis and hair loss in a patient.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.